In the ongoing Andis case, federal prosecutor Carlos Rívolo has called for the indictment of Hernán Daniel Díaz, the head of systems at Droguería Suizo Argentina, who is accused of obstructing access to emails that are vital for the investigation into the inflated pricing of medications. The investigation focuses on allegations that Suizo Argentina has been engaged in corrupt practices, which include negotiating illicitly and preventing transparency in the sale of high-cost drugs to the National Disability Agency (Andis). This case raises serious concerns about the misuse of resources intended for individuals with disabilities.

The probe has already led to charges against former Andis head Diego Spagnuolo and 18 others, including notable figures like Daniel Garbellini, Miguel Ángel Calvete, and Pablo Atchabahian, who are implicated in various forms of corruption linked to the facility's procurement processes. These accusations contribute to a broader narrative of corruption in public health procurement in Argentina, highlighting systemic risks and abuse of power that prioritize profit over public welfare.

If Díaz is indicted, it could set a significant precedent in holding individuals accountable for obstructing justice in corruption cases, particularly those affecting vulnerable populations seeking medical support. The implications of this case extend beyond the individuals involved, calling into question the integrity of public health institutions and their operations, and possibly leading to reforms in how public funds are managed and monitored.